Showing results (81-90 of 272) with videos related to

Sort By:
Pageof 28
Cancers|May 26, 2018
A Phase II Study of Pelareorep (REOLYSIN®) in Combination with Gemcitabine for Patients with Advanced Pancreatic AdenocarcinomaDevalingam Mahalingam, Sanjay Goel, Santiago Aparo, et al.
Annals of Surgical Oncology|August 3, 2020
Short-Term Risk of Performing Concurrent Procedures with Hepatic Artery Infusion Pump PlacementBrian C Brajcich, David J Bentrem, Anthony D Yang, et al.
British Journal of Cancer|July 13, 2023
Combination of pembrolizumab and pelareorep promotes anti-tumour immunity in advanced pancreatic adenocarcinoma (PDAC)Devalingam Mahalingam, Siqi Chen, Ping Xie, et al.
Pediatric Physical Therapy : the Official Publication of the Section on Pediatrics of the American Physical Therapy Association|November 18, 2011
Predictors of Standardized Walking Obstacle Course outcome measures in children with and without developmental disabilitiesKaren M Kott, Sharon L Held, Elizabeth Francis Giles, et al.
British Journal of Clinical Pharmacology|March 25, 2020
Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumoursDevalingam Mahalingam, Manish R Patel, Jasgit C Sachdev, et al.
Journal of Surgical Oncology|October 4, 2022
Neoadjuvant therapy use and association with postoperative outcomes and overall survival in patients with extrahepatic cholangiocarcinomaCasey M Silver, Rachel H Joung, Charles D Logan, et al.
Communications Medicine|January 13, 2024
First-in-human phase I dose escalation trial of the first-in-class tumor microenvironment modulator VT1021 in advanced solid tumorsDevalingam Mahalingam, Wael Harb, Amita Patnaik, et al.
Journal of Hematology & Oncology|November 13, 2025
First in human phase 1 study of DT2216, a selective BCL-xL degrader, in patients with relapsed/refractory solid malignanciesDaruka Mahadevan, Minal Barve, Devalingam Mahalingam, et al.
Oncotarget|June 19, 2023
Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancerDevalingam Mahalingam, Salih Hanni, Anthony V Serritella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2019
Pembrolizumab in Combination with the Oncolytic Virus Pelareorep and Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma: A Phase Ib StudyDevalingam Mahalingam, Grey A Wilkinson, Kevin H Eng, et al.
Pageof 28